DECR1 is sufficient to restrict breast cancer cell proliferation through its ability to limit the extent of oncogene expression and reduce the stable level of de novo fatty acid synthesis (Ursini-Siegel et al., 2007). Here, DECR1 is linked to breast carcinoma.